| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |